This story was originally published by the WND News Center.

President Donald Trump is signing a new executive order that specifically is expected to bring down the costs of prescription drugs for Americans.

White House spokeswoman Karoline Leavitt explained that the order "will help bypass costly middlemen and bring the prices Americans pay for prescription drugs in line with those paid by other nations."

The order is the result of a "historic" deal with Pfizer "to slash drug prices," reports Tuesday confirmed.

The announcement said now Pfizer "is committing to offer" all of the company's prescription medications to Medicaid at the prices also paid by its "most favored nations."

In addition to Medicaid, all consumers also are expected to benefit through access to those medications.

A report at the Washington Examiner explained the result will be a direct-to-consumer website for Americans to purchase their medications.

Leavitt announced the "TrumpRx" website.

The report noted details still are being addressed.

"It is unclear what drugs will be offered on the website and whether or not it will be accessible to patients with private insurance, Medicare, or Medicaid," the report said.

Further, the Pharmaceutical Research and Manufacturers of America, the industry's chief lobbying group, said it is launching a similar effort to make connections between patients needing medications and direct purchasing programs.

The report said, "Increasing access to direct-to-consumer prescription plans was a central pillar of Trump's "most favored nation" executive order in May, which was intended to reduce U.S. drug prices in parity with other developed countries."

Trump's goal was triggered by the fact Americans pay three times more for brand name prescriptions than do people in other developed countries, the White House has revealed.

According to Newsweek, Trump's plan will allow consumers to buy prescriptions directly, rather than through insurance.